News & Analysis on Clinical Trial Services & Contract Research And Development
Many drugs cannot be administered orally since they cannot be taken up in the gastrointestinal tract. All attempts to solve this problem have thus far resulted in unacceptable risks of side effects, mainly because the intestinal wall is so severely...
Denmark-based vaccines company Bavarian Nordic is investing DK 250 million (€33.6m) in a production facility that will be the largest of its kind in Europe, producing up to 120 million vaccine doses a year.
UK firm Cobra Biomanufacturing has ended its first year as a publicly-listed company with a healthy 137 per cent increase in revenues to £6 million (€8.6m), helped by an expansion of its business in the US.
Tecan UK has launched a new plate-handling add-on for its Aquarius multi-channel pipetting system that should increase the throughput of the device, which is used for applications such as assay development and drug screening.
The pharmaceutical industry has welcomed the passage of new legislation by the UK Parliament that will give police new powers to intervene in public order offences, including those carried out by animal extremist groups.
A new low-calorie sweetener which tastes just like table sugar and is suitable for use in pharmaceuticals and other health care products is now available from Biospherix, a subsidiary of US firm Spherix Incorporated.
US packaging specialist Advantek has sold its Vaculok range of vacuum-insulated panels to MOCON, an instrumentation company serving the medical, pharmaceutical and food industries.
Cefic, the European chemical industry council, has announced a €100,000 prize for innovative research in the field of toxicology.
Despite the best efforts of specialist software development companies and millions of dollars in spending on dedicated programmes, the most commonly used package in the drug discovery laboratory is Microsoft's office workhorse Excel.
Akzo Nobel opened a new biotech vaccines production facility in Boxmeer, the Netherlands, yesterday, that signposts a new ambition in human vaccines for the group.